Skip to content
Ablacon
Ablacon
Electrographic Flow - see what matters.
  • Home
  • HRS 2023
  • News
  • Publications
  • Team
  • Contact
  • Privacy Policy

Electrographic Flow (EGF)

Our technology visualizes in real-time what is going on in the heart. We compute the electrographic flow which allows to treat atrial fibrillation faster, more precisely and more reliably.

Learn more

Ablamap® System and Ablacath is FDA 510(k) cleared for use in the United States.
Caution: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use for information on Indications, Contraindications, Warnings, Precautions and Adverse events.
Copyright © 2023 Ablacon, Inc.